Savara inc. (SVRA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities:
Net loss

-81,482

-78,173

-56,968

-57,125

-46,779

-61,516

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-30,762

-36,100

-40,228

-41,988

-41,433

-39,842

-36,992

-34,946

-31,947

-28,702

-27,093

-24,480

-22,270

-21,480

0

0

0

Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

-

-

78

99

127

140

148

146

130

117

103

85

0

0

0

-

-

-

-

Depreciation and amortization including right-of-use assets

945

1,010

911

805

726

526

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of debt issuance costs and debt discount

-

-

-

-

-

-

-

-

-

-

-

-

944

1,009

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Expenses related to options issued to non-employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Expenses paid by issuance of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Expenses paid by issuance of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Expenses paid by issuance of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Expenses related to stock warrants issued

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Equity in loss of investee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Acquired in-process research and development (Note 7)

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Impairment of acquired IPR&D

-

-

-

-

-

21,692

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on bargain purchase

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of debt discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Forgiveness of employee receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Impairment of goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in fair value of financial instruments

-134

-213

-266

-120

-45

-64

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of contingent consideration

-

264

399

533

533

266

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash interest (income) expense

65

-72

34

-48

36

75

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency (gain) loss

137

-78

151

28

73

71

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

569

582

568

537

506

468

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion on discount to short-term investments

888

1,161

1,358

1,310

1,104

900

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

4,635

4,441

4,237

5,080

4,325

3,737

2,994

1,120

503

552

1,042

1,573

2,445

2,643

2,504

2,403

2,268

2,675

2,641

2,786

2,699

2,032

1,953

1,707

1,647

1,600

0

0

0

Loss on disposals of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Loss on fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Loss on change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-35

0

0

0

Gain on bargain purchase

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

486

0

0

0

-

-

-

-

Benefit for deferred taxes

-

-

-

-

-

-7,057

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of license agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Impairment of equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cumulative effect of change in accounting principle

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Amortization of premium / (accretion of discount) on investments in securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Changes in operating assets and liabilities:
Prepaid expenses and other current assets

116

-148

-1,718

-1,296

-915

-900

1,716

2,028

3,025

2,564

947

1,031

-725

-363

-302

-714

272

-13

370

271

-178

58

519

369

428

490

0

0

0

Non-current assets

-263

-131

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses and other current liabilities

-3,565

568

584

3,131

3,053

1,546

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term liabilities

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease in accounts payable

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Increase/(decrease) in accrued liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

2,584

1,682

1,881

2,507

0

0

0

Net cash used in operating activities

-47,343

-45,123

-45,670

-43,019

-40,463

-39,275

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash flows from investing activities:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-29,118

-37,267

-38,749

-36,036

-36,928

-32,949

-30,153

-27,265

-25,721

-24,645

0

0

0

-

-

-

-

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash acquired through Merger

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,534

0

0

0

-

-

-

0

Purchases of certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,713

15,207

19,440

17,986

19,435

15,022

25,964

25,724

21,967

0

0

0

Proceeds from maturities of certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

11,322

15,207

16,501

17,058

16,560

17,024

14,625

17,370

15,827

16,659

17,066

14,336

16,534

17,248

0

0

0

Proceeds from sales of certificates of deposit

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Security deposit for sublease

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of other investment securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from maturities and sales of other investment securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Purchase of property and equipment

56

148

198

208

218

141

0

0

0

-

-

-

-

8

55

81

100

165

128

129

211

147

138

138

48

47

0

0

0

Purchase in-process research and development (Note 7)

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of available-for-sale securities, net

112,524

122,945

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of available-for-sale securities, net

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of available-for-sale securities

113,200

124,700

123,600

129,846

116,246

98,746

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Sale of available-for-sale securities, net

9,262

14,133

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments made on debt facility

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs paid in connection with debt facility

-

-

-

-

-

-

-

-

-

-

-

-

135

123

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payment on obligation under license agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Issuance of note receivable - related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments on note receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Advance to investee

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash transferred in rescission of acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash received in rescission of acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash (used in) provided by investing activities

6,635

15,740

-142

-42,444

-15,689

-13,619

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash flows from financing activities:
Net cash provided by / (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

13,650

15,199

11,217

11,499

8,292

3,395

-710

-2,329

-2,500

481

0

0

0

-

-

-

-

Issuance of common stock upon exercise of warrants

-

-

-

-

-

19

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock upon at the market offerings, net

-

29,592

29,603

23,939

4,902

505

0

0

0

-

-

-

-

19,958

17,942

14,033

10,191

2,140

17,575

19,867

21,916

30,201

14,766

12,474

36,392

28,098

0

0

0

Repayment of debt facility

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from exercise of stock options

152

110

119

92

61

58

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale or exercise of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Proceeds from sale of preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Repurchase of Subject to Vesting Shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Repurchase of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payments for offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

1,089

1,046

972

730

142

1,470

1,572

1,755

2,058

833

954

2,677

2,361

0

0

0

Capital lease obligation principal payments

-

-

-

-

-

546

257

713

700

460

462

9

9

8

8

8

7

7

0

0

0

-

-

-

0

-

-

-

-

Proceeds from issuance of notes payable and detachable warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Cash paid in lieu of fractional shares for reverse stock split

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Net cash (used in) provided by financing activities

49,546

54,908

38,756

78,858

59,818

55,193

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Effect of exchange rate changes on cash and cash equivalents

6

-22

-105

-169

-117

-119

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

8,844

25,503

-7,161

-6,774

3,549

2,180

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-282

7,558

15,846

27,813

24,223

16,798

37,088

24,440

26,307

34,291

0

0

0

-

-

-

-

Effect of exchange rate changes on cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2

0

0

0

Increase / (Decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

31,812

-15,750

-14,510

-11,686

3,276

-4,413

-12,756

6,225

-5,154

-1,914

10,127

-4,248

-18,603

8,438

3,181

0

0

0

Non-cash transactions
Acquisition of in-process research and development (Note 7)

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of cash flow information:
Cash paid for interest and end of period charge due upon debt facility amendment

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

1,406

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-